The field of advanced chemical synthesis is constantly evolving, driven by the need for highly specific and pure compounds that serve as the building blocks for modern pharmaceuticals. (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride (CAS: 1156491-10-9) exemplifies this trend, being a critical intermediate in the complex synthesis of Ticagrelor, a vital antiplatelet medication.

The utility of (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride lies in its precisely defined molecular structure, particularly its (1R,2S) stereochemistry. This specific configuration is not merely an academic detail; it is fundamental to the pharmacological activity of Ticagrelor, ensuring it effectively inhibits P2Y12 receptors to prevent blood clots in patients with acute coronary syndromes. Manufacturers producing this intermediate must employ sophisticated synthesis techniques to achieve this high level of stereochemical control, often alongside an assay purity of ≥98.0%.

The compound's appearance as a white to yellow powder and its need for cool, ventilated storage are typical considerations for high-quality chemical intermediates. For pharmaceutical companies, the ability to source this material reliably is key to maintaining production continuity and meeting market demands for Ticagrelor. This involves a careful selection of suppliers, focusing on those with demonstrated expertise in producing complex organic molecules.

Companies that specialize in fine chemical manufacturing and custom synthesis, such as NINGBO INNO PHARMCHEM CO.,LTD., play a crucial role in the pharmaceutical supply chain. By offering intermediates like (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride, they enable drug developers to streamline their manufacturing processes. The advantage of sourcing from a reliable chemical supplier China offers often translates to competitive pricing and scalable production capacity, allowing companies to buy the intermediate in the quantities required for both research and large-scale manufacturing.

The synthesis of Ticagrelor is a multi-step process where the quality of each intermediate directly influences the yield and purity of the final product. Therefore, investing in a high-quality intermediate like (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride is an investment in the overall success and integrity of the drug manufacturing operation. The expertise of manufacturers in handling sensitive reactions and purification processes ensures that this intermediate meets the demanding specifications of the pharmaceutical industry.

In conclusion, the advanced synthesis and application of (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride underscore the critical link between specialized chemical manufacturing and modern medicine. By prioritizing precise synthesis and reliable sourcing from partners like NINGBO INNO PHARMCHEM CO.,LTD., the pharmaceutical sector can continue to develop and deliver life-saving treatments like Ticagrelor effectively.